Skip to main content

ORIGINAL RESEARCH article

Front. Oncol.
Sec. Gynecological Oncology
Volume 14 - 2024 | doi: 10.3389/fonc.2024.1468160

Analysis of risk factors associated with cervical HPV infection and their effects on female sexual function and anxiety: a multicentre cross-sectional study based on Chinese women

Provisionally accepted
Haoye Wang Haoye Wang 1Keyi Nie Keyi Nie 1*Zixuan Liu Zixuan Liu 1*Yumeng Zhao Yumeng Zhao 2*Yingxin Ha Yingxin Ha 3*Huanyan Zhang Huanyan Zhang 4*Dongwei Mao Dongwei Mao 1*
  • 1 Guangzhou University of Chinese Medicine Shenzhen Hospital (Futian), shenzheng, China
  • 2 Graduate School of Heilongjiang University of Chinese Medicine, Hei Longjiang, China
  • 3 Postgraduate students of the Department of Brain Disease, the First Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, China., Shan xi, China
  • 4 Affiliated Hospital of Shaanxi Institute of Traditional Chinese Medicine, Xi'an, China

The final, formatted version of the article will be published soon.

    This research aimed to explore the determinants of cervical HPV infection and evaluate how cervical cancer screening outcomes influence sexual functioning and anxiety among women across three provinces in China.Methods: Study participants were categorized into HPV-positive or HPV-negative groups, after which they completed the General Characteristics Questionnaire and the SAS Anxiety Scale. The HPV-positive cohort was further divided into four subgroups: Subgroup 1 consisted of individuals with HPV types 16 or 18 but no cytological abnormalities. Subgroup 2 included those with cytological abnormalities and infections with HPV types 16 or 18. Subgroup 3 included participants infected with high-risk HPV types other than 16 and 18, who did not show cytological abnormalities, while Subgroup 4 encompassed individuals with both cytological abnormalities and infections with high-risk HPV types other than 16 and 18. All participants were assessed using the Female Sexual Function Index Scale (FSFI), which measures sexual function across these subgroups.Results: A total of 531 questionnaires were analyzed. Logistic regression identified several risk factors for HPV infection, including manual labor, service occupations, other occupations, low-and middle-income groups, and cervical columnar epithelial ectasia, as well as an increase in the number of previous sexual partners. Conversely, protective factors included condom use during sexual activity and mutual genital hygiene prior to intercourse. The incidence of lower genital tract infections was significantly higher in the HPV-positive group compared to the HPV-negative group, with rates of chlamydia (13.3% versus 4.6%, P<0.001), gonococcal infections (5.2% versus 0.4%, P<0.001), and mycobacterial diseases (38.9% versus 23.4%, P<0.001).Additionally, anxiety levels were significantly higher in the HPV-positive group compared to the HPV-negative group (p<0.005). Anxiety levels and cytological outcomes were significantly correlated across the four HPV-positive subgroups (p<0.05), with type 16/18 infections being associated with notably lower FSFI scores compared to other high-risk HPV types (p<0.05).Conclusions: The findings suggest that infections with HPV type 16/18, especially when accompanied by abnormal cytological findings, significantly elevate anxiety and distress in women and are associated with reduced FSFI scores. These results highlight the complex impact of HPV infection on women's sexual health and psychological well-being.

    Keywords: Cervical HPV infection, Anxiety, Sexual function, cervical cancer, Cross-Sectional Studies

    Received: 21 Jul 2024; Accepted: 20 Sep 2024.

    Copyright: © 2024 Wang, Nie, Liu, Zhao, Ha, Zhang and Mao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Keyi Nie, Guangzhou University of Chinese Medicine Shenzhen Hospital (Futian), shenzheng, China
    Zixuan Liu, Guangzhou University of Chinese Medicine Shenzhen Hospital (Futian), shenzheng, China
    Yumeng Zhao, Graduate School of Heilongjiang University of Chinese Medicine, Hei Longjiang, China
    Yingxin Ha, Postgraduate students of the Department of Brain Disease, the First Affiliated Hospital of Shaanxi University of Traditional Chinese Medicine, China., Shan xi, China
    Huanyan Zhang, Affiliated Hospital of Shaanxi Institute of Traditional Chinese Medicine, Xi'an, China
    Dongwei Mao, Guangzhou University of Chinese Medicine Shenzhen Hospital (Futian), shenzheng, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.